<DOC>
	<DOCNO>NCT00768742</DOCNO>
	<brief_summary>The primary objective study test hypothesis minimum 75 % volume radiofrequency ablation fibroid associate menorrhagia result reduction menstrual bleeding .</brief_summary>
	<brief_title>Safety Effectiveness Study RF Ablation Uterine Fibroids Reduce Menstrual Bleeding : Fibroid Ablation Study</brief_title>
	<detailed_description />
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Menorrhagia</mesh_term>
	<criteria>Premenopausal Regular , consistent menstrual cycle Serum progesterone &gt; 6 ng/ml ( 19 nmol/L ) 2 month history PBLAC score 150500 Maximum 4 type I , type II , intramural fibroid Patient low risk cervical cancer Hemoglobin &gt; 6 g/dl Not risk pregnancy No desire future fertility Willing able complete followup requirement outline study design section protocol Willing sign consent form Subserosal fibroid . Any fibroid obstructs access endometrial cavity FSH &gt; 20 IU/L Pregnancy Evidence disorder hemostasis Use GnRH agonist depomedroxyprogesterone acetate implantable injectable progestin and/or estrogen SERMS/SPRMS within last 6 month Current use IUD use Mirena IUS within last 3 month Gynecological malignancy hyperplasia Known/suspected abdominal/pelvic cancer Active pelvic infection ( e.g. , active salpingitis pelvic inflammatory disease ) Adenomyosis Previous surgical ablative treatment fibroid menorrhagia Previous uterine artery embolization occlusion Patient anticoagulation therapy Needing emergency surgery treat fibroid symptom Concomitant intrauterine polyp . Major medical psychiatric illness affect general health patient 's ability comply followup schedule provide valid patient selfassessment data Contraindication MRI Allergy contrast medium Mild renal insufficiency bad Known renal disease Uncontrolled hypertension last 2 year Diabetes Uterine size &gt; 10 week 10 cm ectocervix fundus .</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Uterine Fibroid RF Ablation</keyword>
	<keyword>Intrauterine Ultrasound</keyword>
	<keyword>VizAblate</keyword>
</DOC>